当前位置:循环首页>正文

预防脑卒中的抗凝治疗--Diener教授专访

作者:国际循环网   日期:2010/3/29 14:00:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

Atrial fibrillation is a common cause of cardioembolic stroke, particularly among the elderly. While warfarin is an effective therapy for the prevention of stroke in atrial fibrillation, there is an underutilization of warfarin in patients who might benefit from this therapy......

<International Circulation>: Warfarin therapy is challenging because there is wide variation among patients in response and therefore in dose requirement. There are some reports on genetic testing to help predict the patient’s response to warfarin therapy. What are the benefits and risks of genetic testing before prescribing warfarin?

Prof. Diener: That is not applicable for those people who have had arterial stroke because you can not wait until you have results of the genetic testing to decide to put someone on anticoagulation or not.

上一页  [1]  [2]  [3]  [4]  [5]  [6]  下一页

版面编辑:沈会会



华法林达比加群酯

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530